Biatain Alginate highly absorbent dressing

Only 2 left
SKU: 3705
Regular price $175.50 CAD

Got questions?

Feel free to get in touch

Product description

Recommended for cavity filling

The design and the structural integrity of the dressing allow you to cut the dressing and make it fit to wounds of many sizes, shapes and depths. The dressing will conform to the wound bed, which is important for the wound healing process.

High dressing integrity

The high dressing integrity allows for one-piece removal of the dressing with minimal pain and trauma (1,2).

Minimized risk of leakage and maceration

The superior absorption of Biatain® Alginate (1,2) and the gel formation, which locks the exudate inside the dressing, prevent leakage that can damage the periwound skin.

Documented hemostatic effect

Contrary to hydrofibre dressings, Biatain® Alginate has documented hemostatic effect, i.e. the ability to arrest blood flow in minor bleedings due to the release of calcium ions from the dressing (4,5).

Mode of action

On contact with wound exudate, Biatain® Alginate converts to a soft, cohesive gel that provides an optimal moist wound healing environment (2).

Product composition

Biatain® Alginate is an alginate dressing consisting of 85% alginate and 15% carboxymethylcellulose (CMC).


Biatain® Alginate can be used on all moderate to heavily exuding partial to full thickness wounds. Biatain® Alginate may assist in supporting the control of minor bleeding in superficial wounds. Biatain® Alginate can be used with compression therapy. Biatain® Alginate should not be used on dry or lightly exuding wounds or to control heavy bleeding. Biatain® Alginate is indicated for pressure ulcers, venous leg ulcers, arterial ulcers, diabetic foot ulcers, donor sites or traumatic wounds.


1. Thomas S et al.

2. Timmons J. Alginate and hydrofiber dressings. Professional Nurse 1999;14(7).


4. Segal HC et al. The effects of alginate and non-alginate wound dressings on blood coagolation and platelet activation. Journal of Biomaterials Applications 1998;249-57.

5. Elalamy I and Robert F. Etude in vitro des effets proactivateurs plaquettaires de deux pansements: Alginate pur (Algostéril) et Alginate-CMC (SeaSorb Soft), etude sur plasma riche en plaquettes. CPC France 2007.